Abstract:Background Embryonic stem cells (ESCs) are pluripotent stem cells and can form tumors containing cells from all three germ layers. Similarities between pluripotent stem cells and malignant tumor cells have been identified. The purpose of this study was to obtain ESCs-converted tumor cell lines and to investigate the mechanism of malignancy in pluripotent stem cells. Methods Mouse ESCs were subcutaneously injected into nude mice to obtain tumors from which a tumor-like cell line (ECCs1) was established by culturing the cells in chemical-defined N2B27 medium supplied with two small molecular inhibitors CHIR99021 and PD0325901 (2i). The ECCs1 were then subcutaneously injected into nude mice again to obtain tumors from which another tumor-like cells line (ECCs2) was established in the same 2i medium. The malignant degree of ESCs, ECCs1 and ECCs2 was compared and the underlying mechanism involved in the malignancy development of ESCs was examined. Results The three ESCs, ECCs1 and ECCs2 cell lines were cultured in the same 2i condition and showed some likeness such as Oct4-expression and long-term expansion ability. However, the morphology and the tumor-formation ability of the cell lines were different. We identified that ECCs1 and ECCs2 gradually acquired malignancy. Moreover, Wnt signaling-related genes such as CD133 and β-catenin expression were up-regulated and Frizzled related protein (FRP) was down-regulated during the tumor development of ESCs. Conclusions The two tumor-like cell lines ECCs1 and ECCs2 stand for early malignant development stage of ESCs and the ECCs2 was more malignant than the ECCs1. Moreover, we identified that Wnt/β-catenin signaling played an important role in the malignancy process of ESCs.

Wnt/beta-catenin signaling in embryonic stem cell converted tumor cells

Wnt Signaling Determines Tumorigenicity And Function Of Esc-Derived Retinal Progenitors

WNT Signaling in Stem Cell Differentiation and Tumor Formation

Wnt/β-catenin Signaling Pathway in Lung Cancer Stem Cells is a Potential Target for the Development of Novel Anticancer Drugs.

Constitutive Expression Of Wnt/Beta-Catenin Target Genes Promotes Proliferation And Invasion Of Liver Cancer Stem Cells

Establishment Of Mouse Teratocarcinomas Stem Cells Line And Screening Genes Responsible For Malignancy

TGFβ Signaling Hyperactivation-Induced Tumorigenicity During the Derivation of Neural Progenitors from Mouse ESCs

Β-Catenin and Associated Proteins Regulate Lineage Differentiation in Ground State Mouse Embryonic Stem Cells

Essentiality of CTNNB1 in Malignant Transformation of Human Embryonic Stem Cells under Long-Term Suboptimal Conditions

Up-regulation of Dsg2 Confered Stem Cells with Malignancy Through Wnt/β-Catenin Signaling Pathway.

Genome-wide RNA-Seq identifies TP53-mediated embryonic stem cells inhibiting tumor invasion and metastasis

Tumourigenic Characteristics of Embryonal Carcinoma Cells As A Model for Studying Tumour Progression of Human Embryonic Stem Cells

Bmi1 Severs As a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma

WTAP/IGF2BP3 Mediated M6a Modification of the EGR1/PTEN Axis Regulates the Malignant Phenotypes of Endometrial Cancer Stem Cells

Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer

Β-Catenin/lef1 Transactivates the Microrna-371-373 Cluster That Modulates the Wnt/β-catenin-signaling Pathway

Suppression of Malignancy by Smad3 in Mouse Embryonic Stem Cell Formed Teratoma

Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells.

Establishment and Characterization of a Patient-Derived Metastatic Extraskeletal Ewing Sarcoma Cell Line ES-ZSS-1

A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors.

Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse